Fatovich Daniel M, Dessauer Paul, Ezard Nadine
Emergency Medicine, Royal Perth Hospital, University of Western Australia, Perth, Western Australia, Australia.
Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia.
Emerg Med Australas. 2024 Dec;36(6):990-992. doi: 10.1111/1742-6723.14478. Epub 2024 Aug 1.
Patients presenting to the ED after using illicit drugs, including novel psychoactive substances, are a unique source of information on substances that are directly causing acute harm in the community. Conventionally, illicit drug intoxications are assessed and managed in EDs based on self-report and presenting symptoms, with no objective data on the causative agent. The Emerging Drugs Network of Australia (EDNA) is a national toxico-surveillance system that provides analytic data on these drugs, from sentinel Emergency Departments. It is a collaborative national network of emergency physicians, toxicologists, forensic laboratories and public health authorities. The key benefit of EDNA is the capacity to provide timely laboratory-confirmed toxicology data on emerging drug-related threats in the community. This leads to improvements in clinical, forensic laboratory and public health harm reduction responses, reflecting rapid translation of the research.
使用包括新型精神活性物质在内的非法药物后前往急诊科就诊的患者,是有关正在社区中直接造成急性伤害的物质的独特信息来源。传统上,急诊科对非法药物中毒的评估和处理是基于患者自述和呈现出的症状,而没有关于致病药物的客观数据。澳大利亚新兴药物网络(EDNA)是一个全国性的毒物监测系统,它从定点急诊科提供有关这些药物的分析数据。它是由急诊医生、毒理学家、法医实验室和公共卫生当局组成的全国性协作网络。EDNA的主要优势在于能够及时提供经实验室确认的有关社区中新出现的与药物相关威胁的毒理学数据。这带来了临床、法医实验室和公共卫生减少伤害应对措施的改进,体现了研究成果的快速转化。